Document Detail

Microsurgical treatment of temporal lobe cavernomas.
MedLine Citation:
PMID:  20872256     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Cavernomas of the temporal lobe occur in 10-20% of patients with cerebral cavernomas. They frequently cause epileptic seizures, some of which tend to become refractory to medical therapy. Surgical removal of safely achievable symptomatic lesions has been frequently consistent with good long-term outcome. In the present study, a postoperative outcome is assessed.
METHODS: Of our 360 consecutive patients with cerebral cavernomas, 53 (15%) had a single cavernoma in the temporal lobe. Forty-nine patients were treated surgically and were included in the study. All data were analyzed retrospectively. The cavernomas were allocated into three groups based on the temporal lobe site: medial, anterolateral, and posterolateral. To collect follow-up data, all available patients were interviewed by phone. Seizure outcome was assessed using the Engel classification and general outcome using the Glasgow Outcome Scale (GOS).
RESULTS: Patients' median age at presentation was 37 (range, 7-64) years, with a female/male ratio of 2.5:1. Epileptic seizures occurred in 40 patients (82%). Median duration of seizures preoperatively was 3 (range, 0.1-23) years. In addition, four patients (10%) had memory disorder. Three patients without history of seizures (6%) complained of headache and two (4%) had memory problems. Three patients (6%) had an incidental cavernoma. Hemorrhage occurred in nine patients (18%) preoperatively. Median postoperative follow-up time was 6 (range, 0.2-26) years. Favorable seizure outcome (Engel class I and II) was registered in 35 patients (90%). Ten patients (25%) who had only a single seizure before surgery were seizure free during postoperative follow-up. Good general outcome (GOS, 4.5) was detected in 46 patients (96%). Two patients (4%) developed a new mild memory deficit after surgery, and in two patients existing memory deficits worsened.
CONCLUSIONS: Microsurgical removal of temporal lobe cavernomas is a safe and effective method to improve seizure outcome in patients with medically intractable epilepsy and to prevent deterioration caused by hemorrhage.
Juri Kivelev; Mika Niemelä; Göran Blomstedt; Reina Roivainen; Martin Lehecka; Juha Hernesniemi
Related Documents :
7574466 - Safety of intravenous valproate.
9109896 - Outcome following surgery in patients with bitemporal interictal epileptiform patterns.
9065536 - Long-term follow-up after temporal lobe resection for lesions associated with chronic s...
11136356 - Clinical epidemiology of guillain-barré syndrome in adults in sweden 1996-97: a prospe...
3542346 - Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophyla...
24014466 - The golden hour of stroke intervention: effect of thrombectomy procedural time in acute...
Publication Detail:
Type:  Journal Article     Date:  2010-09-26
Journal Detail:
Title:  Acta neurochirurgica     Volume:  153     ISSN:  0942-0940     ISO Abbreviation:  Acta Neurochir (Wien)     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0151000     Medline TA:  Acta Neurochir (Wien)     Country:  Austria    
Other Details:
Languages:  eng     Pagination:  261-70     Citation Subset:  IM    
Department of Neurosurgery, Helsinki University Central Hospital, Topeliuksenkatu 5, 00260, Helsinki, Finland,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPAR?1-3 mRNA expression in ...
Next Document:  Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrath...